[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 18, 1985

Multifactorial Primary Prevention of Cardiovascular Diseases in Middle-aged MenRisk Factor Changes, Incidence, and Mortality

Author Affiliations

From the Second Department of Medicine (Drs Miettinen, Strandberg, Mattila, and Kumlin) and the Department of Public Health Science (Dr Sarna), University of Helsinki; the National Public Health Institute, Helsinki (Dr Huttunen); and the Jorvi Hospital, Espoo, Finland (Dr Naukkarinen).

JAMA. 1985;254(15):2097-2102. doi:10.1001/jama.1985.03360150073027
Abstract

In a randomized five-year multifactorial primary prevention trial of vascular diseases, hyperlipidemias, hypertension, smoking, obesity, and abnormal glucose tolerance of the high-risk test group (n=612 men) were treated with dietetic-hygienic measures and hypolipidemic (mainly probucol and clofibrate) and antihypertensive (mainly diuretics and β-blockers) agents. A matched high-risk control group (n=610) and a low-risk control group (n=593) were not treated. The program markedly improved the risk factor status, yet the five-year coronary incidence tended to be higher in the intervention group than in the control group (3.1% vs 1.5%), while the stroke incidence was significantly reduced (1.3% vs 0%). The coronary events tended to be accumulated in subgroups treated with β-blocking agents or clofibrate, but there were few in those receiving probucol or diuretics. Thus, the intervention program significantly reduced development of stroke, but the occurrence of cardiac events was not prevented. Possible adverse drug effects offsetting the probable benefit of improved risk profile are not excluded.

(JAMA 1985;254:2097-2102)

×